Online Treatment Tool for Patients: Key Information You Need to Know About Your HER2-Positive Early Breast Cancer Diagnosis

Source: Treatment Options From 5 Experts for Patients With HER2-Positive Early-Stage Breast Cancer
Download PDF
Download this PDF consultation checklist with useful questions for your oncologist about your new HER2-positive early breast cancer diagnosis. You can then enter the specific information about your cancer into our interactive treatment tool by answering a series of multiple choice questions to see treatment options chosen by 5 breast cancer experts.
Format: Adobe Acrobat (.pdf)
File Size: 137 KB
Released: March 19, 2019

Acknowledgements

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo
Contact Info

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Produced in collaboration with
Grace Logo
This activity is supported by an educational grant from
Genentech

Related Content

In this downloadable slideset from Clinical Care Options (CCO) Nadia Harbeck, MD, PhD examines the evidence on checkpoint inhibitor therapy in TNBC.

person default Nadia Harbeck, MD, PhD Released: May 11, 2021

In this downloadable slideset from Clinical Care Options (CCO) Ian Krop, MD, PhD explores the evolving role of antibody-drug conjugates in TNBC.

Ian E. Krop, MD, PhD Released: May 11, 2021

Comentario clínico en español sobre la reclasificación molecular de los cánceres de endometrio y ensayos clave de inmunoterapia en curso, de Clinical Care Options (CCO)

Domenica Lorusso, MD, PhD Released: May 10, 2021

Downloadable slides highlighting strategies for assessing and using biomarkers to guide treatment for patients with NSCLC, by Clinical Care Options.

Matthew Gubens, MD, MS Lauren L. Ritterhouse, MD Released: May 7, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue